- Covid: AstraZeneca vaccine 79% effective with no increased blood clot risk – US trial | Study of over 32,000 people included review of risks of cerebral venous sinus thrombosis https://www.theguardian.com/society/2021/mar/22/astrazeneca-covid-vaccine-79-effective-with-no-increased-blood-clot-risk-us-trial 393 comments worldnews
Linked pages
- Netherlands joins Ireland in vaccine suspension over blood clot concerns | Coronavirus | The Guardian https://www.theguardian.com/world/2021/mar/14/ireland-suspends-oxford-astrazeneca-covid-vaccine-over-blood-clot-concerns 5 comments
- Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA | Coronavirus | The Guardian https://www.theguardian.com/world/2021/mar/15/germany-suspends-oxford-vaccine-over-blood-clot-fears 3 comments